Walleye Capital LLC Tango Therapeutics, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.51 - $12.88 $67,514 - $115,791	-8,990 Reduced 40.56%	13,172 $104,000
Q4 2023 Feb 14, 2024	BUY	$6.52 - $12.01 $144,496 - $266,165	22,162 New	22,162 $219,000
Q4 2022 Feb 14, 2023	SELL	$3.41 - $8.29 $391,399 - $951,526	-114,780 Reduced 28.37%	289,867 $2.1 Million
Q3 2022 Nov 14, 2022	BUY	$3.25 - $5.46 $1.32 Million - $2.21 Million	404,647 New	404,647 $1.47 Million
Q4 2021 Mar 03, 2022	SELL	$9.55 - $14.29 $395,513 - $591,820	-41,415 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.56 - $17.3 $395,927 - $716,479	41,415 New	41,415 $535,000

121

89.1M

2.6K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $521M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.